0001804567-25-000004.txt : 20250827 0001804567-25-000004.hdr.sgml : 20250827 20250827165936 ACCESSION NUMBER: 0001804567-25-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250825 FILED AS OF DATE: 20250827 DATE AS OF CHANGE: 20250827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mottola Frank CENTRAL INDEX KEY: 0001804567 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 251266255 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 wk-form4_1756328373.xml FORM 4 X0508 4 2025-08-25 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001804567 Mottola Frank C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE ROCKVILLE MD 20850 0 1 0 0 SVP, Quality, GMP, Ops, IT 0 Common Stock 2025-08-25 4 M 0 14000 12.98 A 29496 D Common Stock 2025-08-25 4 S 0 14000 44.51 D 15496 D Employee Stock Option (Right to Buy) 12.98 2025-08-25 4 M 0 14000 0 D 2026-03-01 Common Stock 14000 0 D Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026. The option vests in four equal annual installments beginning on March 1, 2017. /s/ Timothy C. Dec, as attorney-in-fact 2025-08-27